Galmed Pharmaceuticals Ltd. buy Barclays PLC
Start price
08.08.24
/
50%
€0.26
Target price
08.08.25
€85.19
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 08.08.25. The prediction end date can be changed by Barclays_PLC at any time.Performance without dividends (%)
Name | 1w |
---|---|
Galmed Pharmaceuticals Ltd. | - |
iShares Core DAX® | -1.941% |
iShares Nasdaq 100 | -3.642% |
iShares Nikkei 225® | -2.728% |
iShares S&P 500 | -3.440% |
Comments by Barclays_PLC for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Barclays PLC from $85.00 to $93.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.40
09.05.24
09.05.24
€78.88
09.05.25
09.05.25
-34.34%
07.08.24
07.08.24